Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Illumina WGS MRD assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Illumina
Type:
Laboratory Developed Test
Related tests:
‹
TruSeq®Amplicon - Cancer Panel (5)
TruSight Oncology 500 Assay (3)
Praxis Extended RAS Panel (2)
Illumina Focus Panel
TruSight Hereditary Cancer Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology 500 HRD Assay
TruSight Oncology 500 ctDNA v2
TruSight Oncology Comprehensive
TruSight RNA Pan-Cancer Panel
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
TruSeq®Amplicon - Cancer Panel (5)
TruSight Oncology 500 Assay (3)
Praxis Extended RAS Panel (2)
Illumina Focus Panel
TruSight Hereditary Cancer Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology 500 HRD Assay
TruSight Oncology 500 ctDNA v2
TruSight Oncology Comprehensive
TruSight RNA Pan-Cancer Panel
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
›
Details
Evidence
News
Illumina WGS MRD assay will detect ctDNA for MRD assessment in research settings that evaluate samples from patients previously diagnosed with cancer across multiple solid tumor indications.
Cancer:
Solid Tumor
Method:
Whole genome sequencing
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login